Clinical research represents new hope for patients by advancing promising medicines that treat disease or improve quality of life. Without clinical trials, there would be no vaccines, or new medicines. Yet there is an urgent need for patients to participate in clinical trials.
Only 5% of patients participate in clinical trials, due to lack of awareness and misconceptions about the research process.
According to consumer research conducted by the Center for Information and Study of Clinical Research Participation (CISCRP), a patient’s physician is the most likely route for a patient to consider clinical trial participation. Findings revealed 62% of patients consider their doctor as the top preferred source for finding a clinical trial. 83% of patients consider their physician’s recommendation a top factor influencing their decision to participate.
Accel Research Sites offer clinical trial studies at three locations in Florida and Alabama, and in local physicians’ practices. In an effort to bring more research into the community it serves, Accel has partnered with additional physicians to offer research studies within their own medical facilities.
At these facilities, Accel’s clinical staff will provide oversight and guidance to conduct clinical trials according to regulatory standards and protocol criteria. In addition, Accel handles all study regulatory, documentation and quality assurance activities. The attending physician serves as the principle investigator, and provides access to patient who meet eligibility criteria and are interested in taking part in a clinical trial.
“We are committed to expanding to clinical trial participation to our community in new and innovative ways. Accel’s goal is to support community physicians through the research process, while offering more study opportunities to more patients,” said Carlos Orantes, Chief Executive Officer of Accel Research Sites. “We ensure protocol and regulatory compliance for every study that is conducted at these facilities, allowing these physicians to focus on patient care.”
Accel Clinical Research today announced the appointment of Melanie VanDemark, M.D., FAAFP as Vice President of Medical Affairs. In this role, Dr. VanDemark will oversee conduct and provide medical guidance for all Accel Research Sites, located in Deland and Port Orange, Florida and Birmingham, Alabama.
All sites specialize in the conduct of Phase I-IV clinical trials to assess the safety and efficacy of promising investigational medicines and medical devices. As a principle investigator, Dr. VanDemark will also provide medical oversight of clinical studies at Avail Clinical Research, the company’s flagship site located in Deland, Florida.
“The current drug development pipeline is thriving with promising medicines and potential breakthrough treatments for many chronic and life-threatening diseases,” said Carlos Orantes, Chief Executive Officer of Accel Clinical Research. “Strong medical leadership is essential for managing today’s complex clinical trials, which prompted us to bring Dr. Vandemark to Accel in a full-time capacity. She brings a wealth of expertise in clinical research from her tenure as an investigator and a deep understanding of the patient from her many years as a family physician and university student health medical director.”
In addition to serving as a principal investigator at Accel, Dr. VanDemark has worked as a family physician. Most recently, she worked for Florida Hospital HealthCare Partners. Previously, she was a family physician and owner of Deland Family Medicine.
Since 2008, Dr. VanDemark has held the position of Clinical Assistant Professor at Florida State University College of Medicine. She is board-certified by the American Board of Obesity Medicine and the American Board of Family Medicine. Dr. VanDemark has also been awarded the distinction of Fellow of the American Academy of Family Physicians.
Dr. VanDemark earned her doctor of medicine degree from Loyola University Stritch School of Medicine. She received a bachelor of science degree in biological sciences and a minor degree in chemistry from Illinois State University. Dr. VanDemark completed her residency at Halifax Family Medicine Residency Program in Florida where she was elected and served as Chief Resident.